Skip to main content
SpringerLink
Log in

GSK's inactivated quadrivalent seasonal influenza vaccine: no serious AEs in 2019/2020 season

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. GlasxoSmithKline Biologicals SA funded, and was involved in, all stages of the study.

Reference

  • Salamanca de la Cueva I, et al. Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season. Drug Safety : 25 Oct 2021. Available from: URL: http://doi.org/10.1007/s40264-021-01121-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

GSK's inactivated quadrivalent seasonal influenza vaccine: no serious AEs in 2019/2020 season. Reactions Weekly 1880, 9 (2021). https://doi.org/10.1007/s40278-021-04843-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-04843-3

Search

Navigation